These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6426865)
41. Regulation of epidermal proliferation and differentiation in psoriasis. Voorhees JJ J Dermatol; 1978 Dec; 5(6):241-55. PubMed ID: 219049 [No Abstract] [Full Text] [Related]
42. Metabolic aspects of psoriasis: the basis for specific therapy. Anderson TF; Voorhees JJ Postgrad Med; 1980 Jun; 67(6):135-8, 141-3, 147-9. PubMed ID: 6246480 [TBL] [Abstract][Full Text] [Related]
43. Role of prostaglandins in inflammatory and proliferative skin disease. Greaves MW Nihon Hifuka Gakkai Zasshi; 1980 Nov; 90(13 Suppl):1172-8. PubMed ID: 6973646 [No Abstract] [Full Text] [Related]
44. [Effects of anti-inflammatory drugs on the arachidonic acid induced erythema in guinea pigs (author's transl)]. Otomo S; Higuchi S; Tanaka M; Gotoh Y; Osada Y; Ohzeki M Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):185-90. PubMed ID: 6799367 [TBL] [Abstract][Full Text] [Related]
45. [Local treatment of psoriasis with glucocorticosteroids]. Marghescu S Hautarzt; 1985 Jan; 36(1):47-9. PubMed ID: 3972579 [TBL] [Abstract][Full Text] [Related]
46. Psoriasis: is it transplacentally induced? Schmahl W Med Hypotheses; 1980 Sep; 6(9):907-11. PubMed ID: 7432252 [TBL] [Abstract][Full Text] [Related]
48. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Greaves MW; Camp RD Arch Dermatol Res; 1988; 280 Suppl():S33-41. PubMed ID: 2841909 [TBL] [Abstract][Full Text] [Related]
49. [Evaluation of the absorption of salicylic acid in keratolytic therapy]. Montagnani A; Ghetti P; Passarini B; Varotti C; Boni P; Lamedica R G Ital Dermatol Venereol; 1986; 121(4):293-6. PubMed ID: 3759143 [No Abstract] [Full Text] [Related]
50. Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters. Lewis JG; Adams DO Cancer Res; 1986 Nov; 46(11):5696-700. PubMed ID: 3019532 [TBL] [Abstract][Full Text] [Related]
51. [Epidermal prostaglandins and their significance]. Förster W Dermatol Monatsschr; 1984; 170(5):293-301. PubMed ID: 6479401 [No Abstract] [Full Text] [Related]
52. Role of arachidonic acid metabolites in distal dying flap. Zachary LS; Robson MC; Heggers JP; Kirchner PJ Surg Forum; 1979; 30():527-8. PubMed ID: 538685 [No Abstract] [Full Text] [Related]
53. Topical nonsteroidal antipsoriatic agents. 2. 2,3-(Alkylidenedioxy)naphthalene analogues of lonapalene. Venuti MC; Loe BE; Jones GH; Young JM J Med Chem; 1988 Nov; 31(11):2132-6. PubMed ID: 3141623 [TBL] [Abstract][Full Text] [Related]
54. [Hypoxia, uricemia and arachidonic acid metabolism]. Deby C; Deby-Dupont G; Bacq ZM Bull Mem Acad R Med Belg; 1981; 136(4):226-36. PubMed ID: 6796161 [No Abstract] [Full Text] [Related]
55. Eicosanoids in psoriasis. Ruzicka T J Dermatol Sci; 1990 Nov; 1(6):415-23. PubMed ID: 1963080 [No Abstract] [Full Text] [Related]
56. [Retinoids and their metabolism: new therapeutic approaches?]. Baron JM; Skazik C; Merk HF Hautarzt; 2008 Sep; 59(9):745-6. PubMed ID: 18769954 [No Abstract] [Full Text] [Related]
57. Prostaglandins and lung injury. Brigham KL; Ogletree M; Snapper J; Hinson J; Parker R Chest; 1983 May; 83(5 Suppl):70S-72S. PubMed ID: 6404608 [No Abstract] [Full Text] [Related]
58. The effect of topical isoprenaline on psoriatic skin. Das NS; Chowdary TN; Sobhanadri C; Rao KV Br J Dermatol; 1978 Aug; 99(2):197-200. PubMed ID: 698108 [TBL] [Abstract][Full Text] [Related]
59. Interactions of anti-inflammatory steroids with PG system in adipose tissue. Lewis GP; Piper PJ Biochem Pharmacol; 1978 May; 27(10):1409-12. PubMed ID: 358988 [No Abstract] [Full Text] [Related]